Mazor Robotics (MZOR) Rating Lowered to Buy at BidaskClub

Mazor Robotics (NASDAQ:MZOR) was downgraded by research analysts at BidaskClub from a “strong-buy” rating to a “buy” rating in a research report issued to clients and investors on Saturday.

Several other research analysts have also commented on the stock. Barclays lowered shares of Mazor Robotics from an “equal weight” rating to an “underweight” rating and decreased their price target for the company from $55.00 to $34.00 in a report on Thursday, October 19th. Zacks Investment Research raised shares of Mazor Robotics from a “sell” rating to a “hold” rating in a report on Thursday, November 16th. Needham & Company LLC reaffirmed a “hold” rating on shares of Mazor Robotics in a report on Wednesday, August 30th. TheStreet raised shares of Mazor Robotics from a “d” rating to a “c-” rating in a report on Wednesday, November 8th. Finally, Ladenburg Thalmann Financial Services set a $54.00 price target on shares of Mazor Robotics and gave the company a “buy” rating in a report on Wednesday, August 30th. Two equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have assigned a buy rating to the company’s stock. Mazor Robotics has an average rating of “Hold” and a consensus target price of $39.83.

Mazor Robotics (NASDAQ MZOR) opened at $57.83 on Friday. Mazor Robotics has a fifty-two week low of $20.50 and a fifty-two week high of $65.97.

A number of large investors have recently modified their holdings of MZOR. JPMorgan Chase & Co. lifted its position in Mazor Robotics by 398.5% in the 1st quarter. JPMorgan Chase & Co. now owns 6,979 shares of the medical instruments supplier’s stock valued at $208,000 after purchasing an additional 5,579 shares during the last quarter. Gilder Gagnon Howe & Co. LLC bought a new stake in Mazor Robotics in the 2nd quarter valued at about $8,014,000. Harel Insurance Investments & Financial Services Ltd. lifted its position in Mazor Robotics by 5.4% in the 2nd quarter. Harel Insurance Investments & Financial Services Ltd. now owns 180,180 shares of the medical instruments supplier’s stock valued at $6,231,000 after purchasing an additional 9,276 shares during the last quarter. BB&T Securities LLC bought a new stake in Mazor Robotics in the 2nd quarter valued at about $248,000. Finally, ProVise Management Group LLC bought a new stake in Mazor Robotics in the 2nd quarter valued at about $422,000. Hedge funds and other institutional investors own 26.46% of the company’s stock.

WARNING: This report was first posted by Community Financial News and is the property of of Community Financial News. If you are reading this report on another website, it was stolen and reposted in violation of United States and international copyright & trademark law. The original version of this report can be viewed at https://www.com-unik.info/2017/12/04/mazor-robotics-mzor-rating-lowered-to-buy-at-bidaskclub.html.

About Mazor Robotics

Mazor Robotics Ltd is an Israel-based medical device company that develops and markets surgical guidance systems and complementary products. It develops computerized and imaging-based systems in the field of spine surgery. Its products include: Renaissance Surgical Guidance System, which enables surgeons to advance from freehand surgical procedures to guided procedures, as well as Food and Drug Administration (FDA)-cleared and European Conformity (CE)-marked Renaissance System, used in spine surgeries, whether open or minimally invasive, for a number of clinical indications.

Analyst Recommendations for Mazor Robotics (NASDAQ:MZOR)

What are top analysts saying about Mazor Robotics Ltd.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Mazor Robotics Ltd. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit